ArticlePharmacoEconomics - open2023

Estimating the Economic and Clinical Value of Introducing Ceftazidime/Avibactam into Antimicrobial Practice in Japan: A Dynamic Modelling Study.

Tetsuya Matsumoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.